nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—breast cancer	0.296	1	CbGaD
Sufentanil—CYP3A4—Exemestane—breast cancer	0.062	0.133	CbGbCtD
Sufentanil—CYP3A4—Letrozole—breast cancer	0.0527	0.113	CbGbCtD
Sufentanil—CYP3A4—Anastrozole—breast cancer	0.047	0.101	CbGbCtD
Sufentanil—CYP3A4—Toremifene—breast cancer	0.043	0.0921	CbGbCtD
Sufentanil—CYP3A4—Fulvestrant—breast cancer	0.04	0.0856	CbGbCtD
Sufentanil—CYP3A4—Thiotepa—breast cancer	0.0356	0.0763	CbGbCtD
Sufentanil—CYP3A4—Ixabepilone—breast cancer	0.0326	0.0698	CbGbCtD
Sufentanil—CYP3A4—Lapatinib—breast cancer	0.0314	0.0672	CbGbCtD
Sufentanil—CYP3A4—Raloxifene—breast cancer	0.0238	0.0509	CbGbCtD
Sufentanil—CYP3A4—Vinorelbine—breast cancer	0.0174	0.0373	CbGbCtD
Sufentanil—CYP3A4—Tamoxifen—breast cancer	0.0157	0.0336	CbGbCtD
Sufentanil—CYP3A4—Mitoxantrone—breast cancer	0.0153	0.0328	CbGbCtD
Sufentanil—CYP3A4—Paclitaxel—breast cancer	0.0122	0.0262	CbGbCtD
Sufentanil—CYP3A4—Irinotecan—breast cancer	0.0121	0.0258	CbGbCtD
Sufentanil—CYP3A4—Vinblastine—breast cancer	0.0107	0.023	CbGbCtD
Sufentanil—CYP3A4—Docetaxel—breast cancer	0.00884	0.0189	CbGbCtD
Sufentanil—CYP3A4—Doxorubicin—breast cancer	0.00659	0.0141	CbGbCtD
Sufentanil—Alfentanil—CYP3A4—breast cancer	0.000493	0.296	CrCbGaD
Sufentanil—Alfentanil—ALB—breast cancer	0.00043	0.258	CrCbGaD
Sufentanil—Alfentanil—ABCB1—breast cancer	0.00041	0.247	CrCbGaD
Sufentanil—Anaphylactic shock—Vinorelbine—breast cancer	0.000369	0.00234	CcSEcCtD
Sufentanil—Arrhythmia—Fluorouracil—breast cancer	0.000366	0.00232	CcSEcCtD
Sufentanil—Somnolence—Goserelin—breast cancer	0.000366	0.00232	CcSEcCtD
Sufentanil—Feeling abnormal—Vinblastine—breast cancer	0.000365	0.00232	CcSEcCtD
Sufentanil—Bronchospasm—Docetaxel—breast cancer	0.000363	0.00231	CcSEcCtD
Sufentanil—Erythema—Gemcitabine—breast cancer	0.000363	0.0023	CcSEcCtD
Sufentanil—Tachycardia—Vinorelbine—breast cancer	0.00036	0.00228	CcSEcCtD
Sufentanil—Erythema—Fluorouracil—breast cancer	0.000357	0.00226	CcSEcCtD
Sufentanil—Hypersensitivity—Chlorambucil—breast cancer	0.000357	0.00226	CcSEcCtD
Sufentanil—Bradycardia—Paclitaxel—breast cancer	0.000355	0.00225	CcSEcCtD
Sufentanil—Nausea—Raloxifene—breast cancer	0.000355	0.00225	CcSEcCtD
Sufentanil—Nausea—Idarubicin—breast cancer	0.000355	0.00225	CcSEcCtD
Sufentanil—Confusional state—Thiotepa—breast cancer	0.000355	0.00225	CcSEcCtD
Sufentanil—Bronchospasm—Capecitabine—breast cancer	0.000352	0.00223	CcSEcCtD
Sufentanil—Urinary tract disorder—Paclitaxel—breast cancer	0.000345	0.00219	CcSEcCtD
Sufentanil—Hypotension—Vinorelbine—breast cancer	0.000344	0.00219	CcSEcCtD
Sufentanil—Tachycardia—Thiotepa—breast cancer	0.000343	0.00218	CcSEcCtD
Sufentanil—Pruritus—Chlorambucil—breast cancer	0.000342	0.00217	CcSEcCtD
Sufentanil—Urethral disorder—Paclitaxel—breast cancer	0.000342	0.00217	CcSEcCtD
Sufentanil—Feeling abnormal—Goserelin—breast cancer	0.000339	0.00215	CcSEcCtD
Sufentanil—Hypersensitivity—Vinblastine—breast cancer	0.000327	0.00207	CcSEcCtD
Sufentanil—Body temperature increased—Goserelin—breast cancer	0.000325	0.00206	CcSEcCtD
Sufentanil—Hypertension—Mitoxantrone—breast cancer	0.000322	0.00204	CcSEcCtD
Sufentanil—Hypertension—Irinotecan—breast cancer	0.000322	0.00204	CcSEcCtD
Sufentanil—Hypersensitivity—Tamoxifen—breast cancer	0.000317	0.00201	CcSEcCtD
Sufentanil—Hypertension—Gemcitabine—breast cancer	0.000313	0.00199	CcSEcCtD
Sufentanil—Chills—Paclitaxel—breast cancer	0.000313	0.00199	CcSEcCtD
Sufentanil—Somnolence—Thiotepa—breast cancer	0.000313	0.00199	CcSEcCtD
Sufentanil—Arrhythmia—Paclitaxel—breast cancer	0.000312	0.00198	CcSEcCtD
Sufentanil—Hypersensitivity—Melphalan—breast cancer	0.000311	0.00197	CcSEcCtD
Sufentanil—Vomiting—Chlorambucil—breast cancer	0.000308	0.00195	CcSEcCtD
Sufentanil—Confusional state—Mitoxantrone—breast cancer	0.000306	0.00195	CcSEcCtD
Sufentanil—Confusional state—Irinotecan—breast cancer	0.000306	0.00195	CcSEcCtD
Sufentanil—Pruritus—Tamoxifen—breast cancer	0.000305	0.00193	CcSEcCtD
Sufentanil—Anaphylactic shock—Mitoxantrone—breast cancer	0.000304	0.00193	CcSEcCtD
Sufentanil—Anaphylactic shock—Irinotecan—breast cancer	0.000304	0.00193	CcSEcCtD
Sufentanil—Erythema—Paclitaxel—breast cancer	0.000304	0.00193	CcSEcCtD
Sufentanil—Feeling abnormal—Vinorelbine—breast cancer	0.000304	0.00193	CcSEcCtD
Sufentanil—Hypersensitivity—Goserelin—breast cancer	0.000303	0.00192	CcSEcCtD
Sufentanil—Pruritus—Melphalan—breast cancer	0.000298	0.00189	CcSEcCtD
Sufentanil—Tachycardia—Mitoxantrone—breast cancer	0.000297	0.00188	CcSEcCtD
Sufentanil—Anaphylactic shock—Gemcitabine—breast cancer	0.000296	0.00188	CcSEcCtD
Sufentanil—Confusional state—Fluorouracil—breast cancer	0.000294	0.00186	CcSEcCtD
Sufentanil—Dizziness—Vinblastine—breast cancer	0.000293	0.00186	CcSEcCtD
Sufentanil—Urinary tract disorder—Docetaxel—breast cancer	0.000292	0.00185	CcSEcCtD
Sufentanil—Bradycardia—Capecitabine—breast cancer	0.000291	0.00185	CcSEcCtD
Sufentanil—Body temperature increased—Vinorelbine—breast cancer	0.000291	0.00185	CcSEcCtD
Sufentanil—Pruritus—Goserelin—breast cancer	0.000291	0.00185	CcSEcCtD
Sufentanil—Anaphylactic shock—Fluorouracil—breast cancer	0.000291	0.00185	CcSEcCtD
Sufentanil—Feeling abnormal—Thiotepa—breast cancer	0.00029	0.00184	CcSEcCtD
Sufentanil—Urethral disorder—Docetaxel—breast cancer	0.00029	0.00184	CcSEcCtD
Sufentanil—Nausea—Chlorambucil—breast cancer	0.000287	0.00182	CcSEcCtD
Sufentanil—Dizziness—Tamoxifen—breast cancer	0.000285	0.00181	CcSEcCtD
Sufentanil—Tachycardia—Fluorouracil—breast cancer	0.000284	0.0018	CcSEcCtD
Sufentanil—Hypotension—Irinotecan—breast cancer	0.000284	0.0018	CcSEcCtD
Sufentanil—Hypotension—Mitoxantrone—breast cancer	0.000284	0.0018	CcSEcCtD
Sufentanil—Urinary tract disorder—Capecitabine—breast cancer	0.000283	0.00179	CcSEcCtD
Sufentanil—Vomiting—Vinblastine—breast cancer	0.000282	0.00179	CcSEcCtD
Sufentanil—Urethral disorder—Capecitabine—breast cancer	0.000281	0.00178	CcSEcCtD
Sufentanil—Body temperature increased—Thiotepa—breast cancer	0.000278	0.00177	CcSEcCtD
Sufentanil—Headache—Vinblastine—breast cancer	0.000278	0.00176	CcSEcCtD
Sufentanil—Hypotension—Gemcitabine—breast cancer	0.000277	0.00176	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—breast cancer	0.000274	0.00174	CcSEcCtD
Sufentanil—Vomiting—Tamoxifen—breast cancer	0.000274	0.00174	CcSEcCtD
Sufentanil—Dizziness—Goserelin—breast cancer	0.000272	0.00173	CcSEcCtD
Sufentanil—Hypotension—Fluorouracil—breast cancer	0.000272	0.00173	CcSEcCtD
Sufentanil—Rash—Tamoxifen—breast cancer	0.000272	0.00172	CcSEcCtD
Sufentanil—Hypersensitivity—Vinorelbine—breast cancer	0.000272	0.00172	CcSEcCtD
Sufentanil—Dermatitis—Tamoxifen—breast cancer	0.000271	0.00172	CcSEcCtD
Sufentanil—Somnolence—Irinotecan—breast cancer	0.00027	0.00172	CcSEcCtD
Sufentanil—Somnolence—Mitoxantrone—breast cancer	0.00027	0.00172	CcSEcCtD
Sufentanil—Headache—Tamoxifen—breast cancer	0.00027	0.00171	CcSEcCtD
Sufentanil—Vomiting—Melphalan—breast cancer	0.000268	0.0017	CcSEcCtD
Sufentanil—Rash—Melphalan—breast cancer	0.000266	0.00169	CcSEcCtD
Sufentanil—Dermatitis—Melphalan—breast cancer	0.000266	0.00169	CcSEcCtD
Sufentanil—Chills—Docetaxel—breast cancer	0.000265	0.00168	CcSEcCtD
Sufentanil—Arrhythmia—Docetaxel—breast cancer	0.000264	0.00168	CcSEcCtD
Sufentanil—Nausea—Vinblastine—breast cancer	0.000263	0.00167	CcSEcCtD
Sufentanil—Somnolence—Gemcitabine—breast cancer	0.000263	0.00167	CcSEcCtD
Sufentanil—Hypertension—Paclitaxel—breast cancer	0.000262	0.00166	CcSEcCtD
Sufentanil—Vomiting—Goserelin—breast cancer	0.000262	0.00166	CcSEcCtD
Sufentanil—Pruritus—Vinorelbine—breast cancer	0.000261	0.00166	CcSEcCtD
Sufentanil—Rash—Goserelin—breast cancer	0.000259	0.00165	CcSEcCtD
Sufentanil—Hypersensitivity—Thiotepa—breast cancer	0.000259	0.00165	CcSEcCtD
Sufentanil—Dermatitis—Goserelin—breast cancer	0.000259	0.00165	CcSEcCtD
Sufentanil—Somnolence—Fluorouracil—breast cancer	0.000259	0.00164	CcSEcCtD
Sufentanil—Headache—Goserelin—breast cancer	0.000258	0.00164	CcSEcCtD
Sufentanil—Erythema—Docetaxel—breast cancer	0.000257	0.00163	CcSEcCtD
Sufentanil—Chills—Capecitabine—breast cancer	0.000257	0.00163	CcSEcCtD
Sufentanil—Nausea—Tamoxifen—breast cancer	0.000256	0.00162	CcSEcCtD
Sufentanil—Arrhythmia—Capecitabine—breast cancer	0.000256	0.00162	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—breast cancer	0.000254	0.00161	CcSEcCtD
Sufentanil—Nausea—Melphalan—breast cancer	0.000251	0.00159	CcSEcCtD
Sufentanil—Feeling abnormal—Mitoxantrone—breast cancer	0.00025	0.00159	CcSEcCtD
Sufentanil—Feeling abnormal—Irinotecan—breast cancer	0.00025	0.00159	CcSEcCtD
Sufentanil—Confusional state—Paclitaxel—breast cancer	0.00025	0.00159	CcSEcCtD
Sufentanil—Erythema—Capecitabine—breast cancer	0.000249	0.00158	CcSEcCtD
Sufentanil—Pruritus—Thiotepa—breast cancer	0.000249	0.00158	CcSEcCtD
Sufentanil—Anaphylactic shock—Paclitaxel—breast cancer	0.000248	0.00157	CcSEcCtD
Sufentanil—Nausea—Goserelin—breast cancer	0.000244	0.00155	CcSEcCtD
Sufentanil—Feeling abnormal—Gemcitabine—breast cancer	0.000244	0.00155	CcSEcCtD
Sufentanil—Dizziness—Vinorelbine—breast cancer	0.000244	0.00155	CcSEcCtD
Sufentanil—Tachycardia—Paclitaxel—breast cancer	0.000242	0.00154	CcSEcCtD
Sufentanil—Body temperature increased—Mitoxantrone—breast cancer	0.00024	0.00153	CcSEcCtD
Sufentanil—Body temperature increased—Irinotecan—breast cancer	0.00024	0.00153	CcSEcCtD
Sufentanil—Feeling abnormal—Fluorouracil—breast cancer	0.00024	0.00152	CcSEcCtD
Sufentanil—Vomiting—Vinorelbine—breast cancer	0.000234	0.00149	CcSEcCtD
Sufentanil—Body temperature increased—Gemcitabine—breast cancer	0.000234	0.00149	CcSEcCtD
Sufentanil—Dizziness—Thiotepa—breast cancer	0.000233	0.00148	CcSEcCtD
Sufentanil—Rash—Vinorelbine—breast cancer	0.000232	0.00147	CcSEcCtD
Sufentanil—Dermatitis—Vinorelbine—breast cancer	0.000232	0.00147	CcSEcCtD
Sufentanil—Hypotension—Paclitaxel—breast cancer	0.000232	0.00147	CcSEcCtD
Sufentanil—Headache—Vinorelbine—breast cancer	0.000231	0.00147	CcSEcCtD
Sufentanil—Body temperature increased—Fluorouracil—breast cancer	0.00023	0.00146	CcSEcCtD
Sufentanil—Hypersensitivity—Irinotecan—breast cancer	0.000224	0.00142	CcSEcCtD
Sufentanil—Hypersensitivity—Mitoxantrone—breast cancer	0.000224	0.00142	CcSEcCtD
Sufentanil—Vomiting—Thiotepa—breast cancer	0.000224	0.00142	CcSEcCtD
Sufentanil—Hypertension—Docetaxel—breast cancer	0.000222	0.00141	CcSEcCtD
Sufentanil—Rash—Thiotepa—breast cancer	0.000222	0.00141	CcSEcCtD
Sufentanil—Dermatitis—Thiotepa—breast cancer	0.000222	0.00141	CcSEcCtD
Sufentanil—Headache—Thiotepa—breast cancer	0.00022	0.0014	CcSEcCtD
Sufentanil—Somnolence—Paclitaxel—breast cancer	0.00022	0.0014	CcSEcCtD
Sufentanil—Nausea—Vinorelbine—breast cancer	0.000219	0.00139	CcSEcCtD
Sufentanil—Hypertension—Capecitabine—breast cancer	0.000215	0.00137	CcSEcCtD
Sufentanil—Hypersensitivity—Fluorouracil—breast cancer	0.000214	0.00136	CcSEcCtD
Sufentanil—Confusional state—Docetaxel—breast cancer	0.000212	0.00134	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—breast cancer	0.00021	0.00134	CcSEcCtD
Sufentanil—Anaphylactic shock—Docetaxel—breast cancer	0.00021	0.00133	CcSEcCtD
Sufentanil—Pruritus—Gemcitabine—breast cancer	0.000209	0.00133	CcSEcCtD
Sufentanil—Nausea—Thiotepa—breast cancer	0.000209	0.00133	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—breast cancer	0.000209	0.00133	CcSEcCtD
Sufentanil—Pruritus—Fluorouracil—breast cancer	0.000206	0.00131	CcSEcCtD
Sufentanil—Confusional state—Capecitabine—breast cancer	0.000205	0.0013	CcSEcCtD
Sufentanil—Tachycardia—Docetaxel—breast cancer	0.000205	0.0013	CcSEcCtD
Sufentanil—Feeling abnormal—Paclitaxel—breast cancer	0.000204	0.0013	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—breast cancer	0.000203	0.00129	CcSEcCtD
Sufentanil—Dizziness—Irinotecan—breast cancer	0.000201	0.00128	CcSEcCtD
Sufentanil—Tachycardia—Capecitabine—breast cancer	0.000199	0.00126	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—breast cancer	0.000197	0.00125	CcSEcCtD
Sufentanil—Hypotension—Docetaxel—breast cancer	0.000196	0.00125	CcSEcCtD
Sufentanil—Body temperature increased—Paclitaxel—breast cancer	0.000196	0.00124	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—breast cancer	0.000196	0.00124	CcSEcCtD
Sufentanil—Vomiting—Mitoxantrone—breast cancer	0.000193	0.00123	CcSEcCtD
Sufentanil—Vomiting—Irinotecan—breast cancer	0.000193	0.00123	CcSEcCtD
Sufentanil—Dizziness—Fluorouracil—breast cancer	0.000192	0.00122	CcSEcCtD
Sufentanil—Rash—Mitoxantrone—breast cancer	0.000192	0.00122	CcSEcCtD
Sufentanil—Rash—Irinotecan—breast cancer	0.000192	0.00122	CcSEcCtD
Sufentanil—Dermatitis—Irinotecan—breast cancer	0.000191	0.00122	CcSEcCtD
Sufentanil—Dermatitis—Mitoxantrone—breast cancer	0.000191	0.00122	CcSEcCtD
Sufentanil—Chills—Methotrexate—breast cancer	0.000191	0.00121	CcSEcCtD
Sufentanil—Headache—Irinotecan—breast cancer	0.00019	0.00121	CcSEcCtD
Sufentanil—Headache—Mitoxantrone—breast cancer	0.00019	0.00121	CcSEcCtD
Sufentanil—Hypotension—Capecitabine—breast cancer	0.00019	0.00121	CcSEcCtD
Sufentanil—Vomiting—Gemcitabine—breast cancer	0.000188	0.00119	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—breast cancer	0.000188	0.00119	CcSEcCtD
Sufentanil—Somnolence—Docetaxel—breast cancer	0.000187	0.00119	CcSEcCtD
Sufentanil—Rash—Gemcitabine—breast cancer	0.000187	0.00118	CcSEcCtD
Sufentanil—Dermatitis—Gemcitabine—breast cancer	0.000186	0.00118	CcSEcCtD
Sufentanil—Erythema—Methotrexate—breast cancer	0.000186	0.00118	CcSEcCtD
Sufentanil—Headache—Gemcitabine—breast cancer	0.000185	0.00118	CcSEcCtD
Sufentanil—Vomiting—Fluorouracil—breast cancer	0.000185	0.00117	CcSEcCtD
Sufentanil—Rash—Fluorouracil—breast cancer	0.000184	0.00117	CcSEcCtD
Sufentanil—Dermatitis—Fluorouracil—breast cancer	0.000183	0.00116	CcSEcCtD
Sufentanil—Hypersensitivity—Paclitaxel—breast cancer	0.000183	0.00116	CcSEcCtD
Sufentanil—Headache—Fluorouracil—breast cancer	0.000182	0.00116	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—breast cancer	0.000182	0.00116	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—breast cancer	0.000181	0.00115	CcSEcCtD
Sufentanil—Nausea—Mitoxantrone—breast cancer	0.000181	0.00115	CcSEcCtD
Sufentanil—Nausea—Irinotecan—breast cancer	0.000181	0.00115	CcSEcCtD
Sufentanil—Fentanyl—CYP3A4—breast cancer	0.00018	0.108	CrCbGaD
Sufentanil—Chills—Epirubicin—breast cancer	0.000179	0.00114	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—breast cancer	0.000178	0.00113	CcSEcCtD
Sufentanil—Nausea—Gemcitabine—breast cancer	0.000176	0.00112	CcSEcCtD
Sufentanil—Pruritus—Paclitaxel—breast cancer	0.000175	0.00111	CcSEcCtD
Sufentanil—Erythema—Epirubicin—breast cancer	0.000174	0.0011	CcSEcCtD
Sufentanil—Feeling abnormal—Docetaxel—breast cancer	0.000173	0.0011	CcSEcCtD
Sufentanil—Nausea—Fluorouracil—breast cancer	0.000173	0.0011	CcSEcCtD
Sufentanil—Feeling abnormal—Capecitabine—breast cancer	0.000168	0.00106	CcSEcCtD
Sufentanil—Body temperature increased—Docetaxel—breast cancer	0.000166	0.00105	CcSEcCtD
Sufentanil—Chills—Doxorubicin—breast cancer	0.000166	0.00105	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—breast cancer	0.000165	0.00105	CcSEcCtD
Sufentanil—Dizziness—Paclitaxel—breast cancer	0.000164	0.00104	CcSEcCtD
Sufentanil—Body temperature increased—Capecitabine—breast cancer	0.000161	0.00102	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—breast cancer	0.000161	0.00102	CcSEcCtD
Sufentanil—Vomiting—Paclitaxel—breast cancer	0.000158	0.001	CcSEcCtD
Sufentanil—Rash—Paclitaxel—breast cancer	0.000156	0.000992	CcSEcCtD
Sufentanil—Dermatitis—Paclitaxel—breast cancer	0.000156	0.000991	CcSEcCtD
Sufentanil—Headache—Paclitaxel—breast cancer	0.000155	0.000986	CcSEcCtD
Sufentanil—Hypersensitivity—Docetaxel—breast cancer	0.000155	0.000983	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—breast cancer	0.000153	0.000969	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—breast cancer	0.000151	0.000961	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—breast cancer	0.00015	0.0903	CrCbGaD
Sufentanil—Hypertension—Epirubicin—breast cancer	0.00015	0.000952	CcSEcCtD
Sufentanil—Hypersensitivity—Capecitabine—breast cancer	0.00015	0.000951	CcSEcCtD
Sufentanil—Pruritus—Docetaxel—breast cancer	0.000149	0.000944	CcSEcCtD
Sufentanil—Nausea—Paclitaxel—breast cancer	0.000147	0.000935	CcSEcCtD
Sufentanil—Pruritus—Capecitabine—breast cancer	0.000144	0.000914	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—breast cancer	0.000143	0.000907	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—breast cancer	0.000142	0.0009	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—breast cancer	0.000141	0.000898	CcSEcCtD
Sufentanil—Dizziness—Docetaxel—breast cancer	0.000139	0.000882	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—breast cancer	0.000139	0.00088	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—breast cancer	0.000138	0.000878	CcSEcCtD
Sufentanil—Somnolence—Methotrexate—breast cancer	0.000135	0.000855	CcSEcCtD
Sufentanil—Dizziness—Capecitabine—breast cancer	0.000135	0.000854	CcSEcCtD
Sufentanil—Vomiting—Docetaxel—breast cancer	0.000134	0.000848	CcSEcCtD
Sufentanil—Rash—Docetaxel—breast cancer	0.000132	0.000841	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—breast cancer	0.000132	0.000841	CcSEcCtD
Sufentanil—Dermatitis—Docetaxel—breast cancer	0.000132	0.00084	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—breast cancer	0.000132	0.000839	CcSEcCtD
Sufentanil—Headache—Docetaxel—breast cancer	0.000132	0.000835	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—breast cancer	0.000131	0.000832	CcSEcCtD
Sufentanil—Vomiting—Capecitabine—breast cancer	0.000129	0.000821	CcSEcCtD
Sufentanil—Rash—Capecitabine—breast cancer	0.000128	0.000814	CcSEcCtD
Sufentanil—Dermatitis—Capecitabine—breast cancer	0.000128	0.000813	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—breast cancer	0.000128	0.000812	CcSEcCtD
Sufentanil—Headache—Capecitabine—breast cancer	0.000127	0.000809	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—breast cancer	0.000126	0.0008	CcSEcCtD
Sufentanil—Nausea—Docetaxel—breast cancer	0.000125	0.000792	CcSEcCtD
Sufentanil—Feeling abnormal—Methotrexate—breast cancer	0.000125	0.000792	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—breast cancer	0.000123	0.000778	CcSEcCtD
Sufentanil—Nausea—Capecitabine—breast cancer	0.000121	0.000767	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—breast cancer	0.00012	0.00076	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—breast cancer	0.000117	0.000741	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—breast cancer	0.000117	0.00074	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—breast cancer	0.000112	0.000711	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—breast cancer	0.000112	0.000708	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—breast cancer	0.000108	0.000686	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—breast cancer	0.000107	0.00068	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—breast cancer	0.000104	0.000663	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—breast cancer	0.000104	0.000658	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—breast cancer	0.0001	0.000636	CcSEcCtD
Sufentanil—Dizziness—Methotrexate—breast cancer	0.0001	0.000636	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—breast cancer	9.66e-05	0.000613	CcSEcCtD
Sufentanil—Vomiting—Methotrexate—breast cancer	9.63e-05	0.000611	CcSEcCtD
Sufentanil—Rash—Methotrexate—breast cancer	9.55e-05	0.000606	CcSEcCtD
Sufentanil—Dermatitis—Methotrexate—breast cancer	9.54e-05	0.000606	CcSEcCtD
Sufentanil—Headache—Methotrexate—breast cancer	9.49e-05	0.000602	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—breast cancer	9.37e-05	0.000595	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—breast cancer	9.28e-05	0.000589	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—breast cancer	9.01e-05	0.000572	CcSEcCtD
Sufentanil—Nausea—Methotrexate—breast cancer	8.99e-05	0.000571	CcSEcCtD
Sufentanil—Rash—Epirubicin—breast cancer	8.94e-05	0.000567	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—breast cancer	8.93e-05	0.000567	CcSEcCtD
Sufentanil—Headache—Epirubicin—breast cancer	8.88e-05	0.000564	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—breast cancer	8.67e-05	0.00055	CcSEcCtD
Sufentanil—Nausea—Epirubicin—breast cancer	8.42e-05	0.000534	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—breast cancer	8.34e-05	0.000529	CcSEcCtD
Sufentanil—Rash—Doxorubicin—breast cancer	8.27e-05	0.000525	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—breast cancer	8.26e-05	0.000524	CcSEcCtD
Sufentanil—Headache—Doxorubicin—breast cancer	8.21e-05	0.000521	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—breast cancer	7.79e-05	0.000494	CcSEcCtD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—breast cancer	1.39e-05	0.000179	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGF—breast cancer	1.38e-05	0.000178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CSF2—breast cancer	1.38e-05	0.000178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF1—breast cancer	1.38e-05	0.000178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—RAF1—breast cancer	1.38e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRG1—breast cancer	1.37e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—H2AFX—breast cancer	1.36e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—breast cancer	1.36e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—breast cancer	1.36e-05	0.000175	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPI—breast cancer	1.35e-05	0.000174	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HADHB—breast cancer	1.35e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—E2F1—breast cancer	1.35e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CAV1—breast cancer	1.35e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	1.35e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK3—breast cancer	1.34e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—breast cancer	1.33e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BRAF—breast cancer	1.32e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SPP1—breast cancer	1.3e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—breast cancer	1.3e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—breast cancer	1.29e-05	0.000167	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.29e-05	0.000166	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.29e-05	0.000166	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB3—breast cancer	1.29e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGFR2—breast cancer	1.28e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FN1—breast cancer	1.28e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—breast cancer	1.28e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT2—breast cancer	1.28e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—breast cancer	1.28e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKBIA—breast cancer	1.27e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH1—breast cancer	1.26e-05	0.000162	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FHL2—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NME1—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADSL—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UMPS—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PHGDH—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—breast cancer	1.24e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—breast cancer	1.23e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—breast cancer	1.23e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIT—breast cancer	1.23e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—breast cancer	1.23e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APC—breast cancer	1.23e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—breast cancer	1.22e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—breast cancer	1.22e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGF—breast cancer	1.21e-05	0.000156	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BRIP1—breast cancer	1.21e-05	0.000156	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LDHB—breast cancer	1.21e-05	0.000156	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPSE—breast cancer	1.21e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—breast cancer	1.21e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGFR1—breast cancer	1.2e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—breast cancer	1.18e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK3—breast cancer	1.18e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—breast cancer	1.16e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BRAF—breast cancer	1.15e-05	0.000149	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA3—breast cancer	1.15e-05	0.000148	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMMR—breast cancer	1.15e-05	0.000148	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCC1—breast cancer	1.15e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—breast cancer	1.15e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CAV1—breast cancer	1.14e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—breast cancer	1.13e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—breast cancer	1.12e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT2—breast cancer	1.12e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—breast cancer	1.12e-05	0.000144	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.11e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	1.11e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MDM2—breast cancer	1.1e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAF1—breast cancer	1.1e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—breast cancer	1.1e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RELA—breast cancer	1.09e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB2—breast cancer	1.09e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FN1—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—breast cancer	1.08e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—breast cancer	1.07e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MTOR—breast cancer	1.07e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKBIA—breast cancer	1.07e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	1.07e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—breast cancer	1.07e-05	0.000137	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH1—breast cancer	1.06e-05	0.000137	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—breast cancer	1.06e-05	0.000136	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA4—breast cancer	1.05e-05	0.000135	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CA9—breast cancer	1.05e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APC—breast cancer	1.04e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—breast cancer	1.04e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIT—breast cancer	1.04e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—breast cancer	1.03e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGF—breast cancer	1.03e-05	0.000132	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX2—breast cancer	1.03e-05	0.000132	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA2—breast cancer	1.03e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRAS—breast cancer	1.02e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—breast cancer	1.02e-05	0.000131	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX4—breast cancer	1.01e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT1A1—breast cancer	1.01e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1B—breast cancer	1.01e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—breast cancer	9.96e-06	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK3—breast cancer	9.94e-06	0.000128	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—IDH1—breast cancer	9.89e-06	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA1—breast cancer	9.89e-06	0.000127	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—breast cancer	9.87e-06	0.000127	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—breast cancer	9.86e-06	0.000127	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—breast cancer	9.81e-06	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NAT2—breast cancer	9.78e-06	0.000126	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BRAF—breast cancer	9.76e-06	0.000126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	9.71e-06	0.000125	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MDM2—breast cancer	9.67e-06	0.000124	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAF1—breast cancer	9.64e-06	0.000124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—breast cancer	9.61e-06	0.000124	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RELA—breast cancer	9.6e-06	0.000124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JUN—breast cancer	9.59e-06	0.000123	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB2—breast cancer	9.54e-06	0.000123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CTNNB1—breast cancer	9.51e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—breast cancer	9.5e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT2—breast cancer	9.5e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—breast cancer	9.46e-06	0.000122	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MTOR—breast cancer	9.41e-06	0.000121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—breast cancer	9.41e-06	0.000121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—breast cancer	9.33e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1A—breast cancer	9.29e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—breast cancer	9.27e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—breast cancer	9.12e-06	0.000117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK8—breast cancer	9.07e-06	0.000117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—breast cancer	9.05e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—breast cancer	9.04e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	9.04e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—breast cancer	9.02e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRAS—breast cancer	8.98e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—breast cancer	8.93e-06	0.000115	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1B—breast cancer	8.83e-06	0.000114	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—breast cancer	8.74e-06	0.000112	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—breast cancer	8.65e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—breast cancer	8.64e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—breast cancer	8.62e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—breast cancer	8.6e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—breast cancer	8.6e-06	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MED12—breast cancer	8.58e-06	0.00011	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DPYD—breast cancer	8.58e-06	0.00011	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDOA—breast cancer	8.44e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—breast cancer	8.42e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JUN—breast cancer	8.41e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—breast cancer	8.38e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CTNNB1—breast cancer	8.34e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—breast cancer	8.29e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	8.21e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA3—breast cancer	8.2e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—breast cancer	8.18e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MDM2—breast cancer	8.17e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1A—breast cancer	8.15e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAF1—breast cancer	8.15e-06	0.000105	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A2—breast cancer	8.14e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—breast cancer	8.13e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RELA—breast cancer	8.11e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB2—breast cancer	8.06e-06	0.000104	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG2—breast cancer	7.97e-06	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTR—breast cancer	7.97e-06	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CPT1A—breast cancer	7.97e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK8—breast cancer	7.95e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MTOR—breast cancer	7.95e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—breast cancer	7.95e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—breast cancer	7.93e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK3—breast cancer	7.92e-06	0.000102	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPGDS—breast cancer	7.82e-06	0.000101	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HBA1—breast cancer	7.77e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—breast cancer	7.71e-06	9.92e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—breast cancer	7.69e-06	9.9e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—breast cancer	7.64e-06	9.84e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRAS—breast cancer	7.59e-06	9.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—breast cancer	7.59e-06	9.76e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACHE—breast cancer	7.59e-06	9.76e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—breast cancer	7.54e-06	9.71e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—breast cancer	7.54e-06	9.7e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1B—breast cancer	7.46e-06	9.61e-05	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—breast cancer	7.38e-06	9.5e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—breast cancer	7.34e-06	9.45e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—breast cancer	7.31e-06	9.42e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—breast cancer	7.3e-06	9.4e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—breast cancer	7.27e-06	9.36e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—breast cancer	7.27e-06	9.35e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP17A1—breast cancer	7.18e-06	9.24e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—breast cancer	7.12e-06	9.17e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—breast cancer	7.12e-06	9.16e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS1—breast cancer	7.11e-06	9.15e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENO1—breast cancer	7.11e-06	9.15e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUN—breast cancer	7.1e-06	9.15e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CTNNB1—breast cancer	7.05e-06	9.08e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2D6—breast cancer	6.97e-06	8.97e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK3—breast cancer	6.95e-06	8.94e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—breast cancer	6.91e-06	8.9e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1A—breast cancer	6.89e-06	8.87e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—breast cancer	6.87e-06	8.85e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA2—breast cancer	6.84e-06	8.81e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—breast cancer	6.76e-06	8.7e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—breast cancer	6.74e-06	8.68e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK8—breast cancer	6.72e-06	8.65e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—breast cancer	6.7e-06	8.63e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FASN—breast cancer	6.64e-06	8.54e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—breast cancer	6.61e-06	8.51e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BCHE—breast cancer	6.61e-06	8.51e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—breast cancer	6.54e-06	8.42e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC5A5—breast cancer	6.53e-06	8.4e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—breast cancer	6.37e-06	8.2e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—breast cancer	6.33e-06	8.15e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NQO1—breast cancer	6.3e-06	8.11e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A1—breast cancer	6.3e-06	8.11e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—breast cancer	6.24e-06	8.04e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—breast cancer	6.21e-06	7.99e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—breast cancer	6.15e-06	7.91e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRAS—breast cancer	6.05e-06	7.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1B1—breast cancer	6.04e-06	7.78e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.93e-06	7.63e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK3—breast cancer	5.87e-06	7.56e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—breast cancer	5.79e-06	7.46e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA1—breast cancer	5.77e-06	7.42e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—breast cancer	5.74e-06	7.38e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—breast cancer	5.71e-06	7.35e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—breast cancer	5.7e-06	7.33e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—STK11—breast cancer	5.68e-06	7.31e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP19A1—breast cancer	5.68e-06	7.31e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—breast cancer	5.59e-06	7.19e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—breast cancer	5.55e-06	7.14e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—breast cancer	5.34e-06	6.88e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRAS—breast cancer	5.31e-06	6.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COMT—breast cancer	5.28e-06	6.8e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—breast cancer	5.28e-06	6.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—breast cancer	5.26e-06	6.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—breast cancer	5.19e-06	6.67e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ITPR1—breast cancer	5.17e-06	6.66e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—breast cancer	5.08e-06	6.54e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—breast cancer	4.98e-06	6.41e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TYMS—breast cancer	4.89e-06	6.29e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—breast cancer	4.85e-06	6.24e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—breast cancer	4.83e-06	6.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOR1—breast cancer	4.83e-06	6.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.83e-06	6.22e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—breast cancer	4.69e-06	6.04e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—breast cancer	4.69e-06	6.03e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—breast cancer	4.63e-06	5.96e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A1—breast cancer	4.58e-06	5.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ERCC2—breast cancer	4.54e-06	5.85e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRAS—breast cancer	4.49e-06	5.77e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—breast cancer	4.29e-06	5.53e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—breast cancer	4.27e-06	5.5e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—breast cancer	3.96e-06	5.1e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAV1—breast cancer	3.94e-06	5.07e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—breast cancer	3.59e-06	4.62e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—breast cancer	3.15e-06	4.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—breast cancer	3.11e-06	4.01e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—breast cancer	2.98e-06	3.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—breast cancer	2.75e-06	3.54e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—breast cancer	2.72e-06	3.51e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—breast cancer	2.38e-06	3.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—breast cancer	1.68e-06	2.16e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—breast cancer	1.37e-06	1.76e-05	CbGpPWpGaD
